Peer-influenced content. Sources you trust. No registration required. This is HCN.
Eyewire+
Bausch + Lomb launched PreserVision AREDS3, a reformulation of its established AREDS2 supplement adding a proprietary B-vitamin complex, citing a narrative review of more than 20 human studies linking B-vitamin supplementation to reduced AMD risk.
Ophthalmology June 1st 2026
Modern Optometry
As we embrace the era of antibody-drug conjugates (ADCs) in cancer therapy, it’s crucial to understand their impact on ocular health. With ADCs like mirvetuximab offering new hope for ovarian cancer patients, effective partnerships between optometrists and oncologists are key to managing associated ocular adverse events.
Optometry October 30th 2023
New pharmaceutical interventions are significantly broadening the scope of presbyopia treatment. Discover how these emerging options can enhance your practice and improve patient care.
Optometry September 26th 2023